Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
Martínez-Cuadrón, David, Boluda, Blanca, Martínez, Pilar, Bergua, Juan, Rodríguez-Veiga, Rebeca, Esteve, Jordi, Vives, Susana, Serrano, Josefina, Vidriales, Belen, Salamero, Olga, Cordón, Lourdes, SemJournal:
Annals of Hematology
DOI:
10.1007/s00277-018-3277-x
Date:
February, 2018
File:
PDF, 286 KB
2018